Board Stats

Navidea Biopharmaceuticals, Inc.

Y! IH NAVB EXPRESS NAVB Advanced Due Diligence NAVB Oldtimers Lounge TME Macrophage Therapeutics Tx Potential-McGrath Basic Immune Cell Functions Immune Cells M1 and M2 Basics 2022- Magical Mystery Tour of Macrophges

NAVB / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
39031	CC Tomorrow	GN	AG_Trader10		1	3/20/2023 6:55:23 PM

39030	NLTX raises-spends $100mm+ fails-$NAVB science team progresses RA/Thx w/limited funds	GN	moneyonomics		1	3/19/2023 6:56:03 PM

39029	Sorafenib cancer treatment performance improves in HCCcarcinoma by M1/M2 reprogamming	GN	moneyonomics		2	3/19/2023 3:52:54 PM

39028	Tilmanocept use in MGH PCSK9 Inhibition trial confirm targeting MR growing importance	GN	moneyonomics		3	3/19/2023 2:09:54 PM

39027	PPVA disses MG	GN	FIRAC		11	3/18/2023 1:20:37 AM

39026	Re: NY MSJ schedule.. status conference this morning at 10:00 am eastern...eom	GN	FIRAC		4	3/17/2023 4:24:20 PM

39025	Re: Erika Resigned	GN	co3aii		0	3/17/2023 11:50:55 AM

39024	Re: NY MSJ schedule.. status conference this morning at 10:00 am eastern...eom	GN	moneyonomics		1	3/17/2023 11:20:27 AM

39023	Re: Erika Resigned	GN	NAVB2023		2	3/17/2023 8:29:22 AM

39022	Re: Erika Resigned	GN	LeapinWizards		1	3/17/2023 7:24:03 AM

Go to Msg #

BOARDS Sign In for Filters